Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Michael Dustin, Director of Research at the Kennedy Institute of Rheumatology has been awarded two major grants this week, one from the European Research Council (ERC) and the other from the Human Frontier Science Program.

Professor Dustin's research at the Kennedy focuses on immunological synapse (IS), a term he first coined to describe the embrace between T cells and B cells that is necessary to mount an immune response.

ERC Advanced Grant

Understanding the immunological synapse is important for innovation in healthcare and the €2.2M Advanced Grant from the ERC will allow Professor Dustin's group at the Kennedy Institute to address fundamental gaps in our understanding of this process.

The five-year project due to start this November aims to reveal the composition of particular structures related to immunological synapses, defined as synaptic ectosomes, as well as identify ways to manipulate their formation.

"These structures add a new dimension to studies on the immunological synapse" says Professor Dustin. "We are very excited to have this opportunity to understand this new phenomenon; we hope to harness what we learn to improve vaccines and immunotherapy."

Human Frontier Science Program

Professor Dustin is part of an international team of experts who will be investigating the formation of antibodies, key agents in the body's response to pathogens.

Coordinated by Prof Michael Meyer-Hermann, a systems biologist of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, the €1.2 million project is funded by the Human Frontier Science Program (HFSP).

Results from the three-year research project will form the foundation for specific interventions into the immune response to infections.

Professor Dustin says: "This is a very exciting opportunity to combine mathematical models and experiments while overcoming barriers to international collaboration."

The research program will focus on the information processing in the germinal centres, highly organized tissues that are generated by infections and vaccines to protect us, but also may produce self-destructive antibodies in autoimmune diseases.

The research team will develop methods to study and manipulate human germinal centres in unprecedented detail using powerful imaging methods. Previous studies have used experiments in mice, as methods to study human germinal centres were not previously available. This approach will overcome limitations of traditional mouse models to study germinal centers, particularly divergence of important regulatory mechanisms between mouse and man.

Professor Meyer-Hermann and Professor Dustin are joined by Dr Gabriel Victora of the Whitehead Institute for Biomedical Sciences, Cambridge, USA, and Prof Carola Vinuesa of the Australian National University in Canberra.

The Human Frontier Science Program only funds teams from different continents and is aimed specifically at establishing international cooperation.

Similar stories

Kennedy researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.

NIHR funding for musculoskeletal and inflammatory disease research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Leducq Foundation grant boosts cardiovascular research

The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.

MRC funding awarded to Kennedy researchers

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”